NYSE:ZTSPharmaceuticals
Zoetis (ZTS) Gains Positive Opinion For Portela Therapy In EU For Cat OA Pain Relief
Zoetis (ZTS) recently received a positive opinion from the European Medicines Agency's CVMP for its pain relief therapy, Portela, expected to enhance its product line for feline osteoarthritis. The company also secured a new $1.25 billion revolving credit facility to bolster its financial flexibility. These developments come amid a mixed market environment where the Nasdaq reached new highs. Despite these advancements, Zoetis' stock declined 3% last month, reflecting broader market dynamics...